Community Research and Development Information Service - CORDIS

Sustained Release Ocular Bevacizumab for the treatment of wet acute macular degeneration

From 2015-05-01 to 2015-10-31, closed project

Project details

Total cost:

EUR 71 429

EU contribution:

EUR 50 000

Coordinated in:

United Kingdom

Objective

Coordinator

CRITICAL PHARMACEUTICALS LIMITED
United Kingdom

EU contribution: EUR 50 000


BIOCITY NOTTINGHAM - PENNYFOOT STREET
NG1 1GF NOTTINGHAM
United Kingdom
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Record Number: 196474 / Last updated on: 2015-04-13